Books
Books
"Stability of Protein Pharmaceuticals: Chemical and Physical Pathways of Protein Degradation", Volume 2 of Pharmaceutical Biotechnology, Tim J. Ahern and Mark C. Manning, Editors, Plenum Press, New York, 1992.
"Stability of Protein Pharmaceuticals: in vivo Pathways of Degradation and Strategies for Protein Stabilization", Volume 3 of Pharmaceutical Biotechnology, Tim J. Ahern and Mark C. Manning, Editors, Plenum Press, New York, 1992.
"Rational Design of Stable Protein Formulations: Theory and Practice", Volume 13 of Pharmaceutical Biotechnology, John F. Carpenter and Mark C. Manning, Editors, Plenum Press, New York, 2002.
Book Chapters
"Pharmaceutical Biotechnology. Protein Stability and Its Enhancement- An Overview", Tim J. Ahern and Mark C. Manning, in Pharmaceutical Biotechnology, Volume 2, Tim J. Ahern and Mark C. Manning, Eds., Plenum Press, New York, 1992, pp. ix-xvii.
"Fibrolase, a Fibrinolytic Protein from Snake Venom", Denise Pretzer, Brenda Schulteis, Chris Smith, David G. Vander Velde, James W. Mitchell, and Mark C. Manning, in Pharmaceutical Biotechnology, Volume 5, Y. J. Wang and R. Pearlman, Eds., Plenum Press, 1993, 287-314.
"Circular Dichroism in the Analysis of Protein Structure", John F. Towell, III and Mark C. Manning, in Analytical Applications of Circular Dichroism, N. Purdie and H.G. Brittain, Eds., Elsevier, 1994, 175-205.
"Two-, Three-, and Four-Dimensional Nuclear Magnetic Resonance Spectroscopy of Protein Pharmaceuticals", David G. Vander Velde, James Matsuura, and Mark C. Manning, in Pharmaceutical Biotechnology, Volume 7, James Herron, Wim Jiskoot, and Daan J.A. Crommelin, Eds., Plenum Press, New York, 1995, 179-218.
"High Throughput Formulation: New Strategies for Developing Stable Protein Formulations", Rajiv Nayar and Mark C. Manning, in Pharmaceutical Biotechnology, Volume 13, John F. Carpenter and Mark C. Manning, Eds., Kluwer Academic/Plenum Press, New York, 2002, 177-198 .
"Effect of Conformation on the Chemical Stability of Polypeptides", Jeffrey D. Meyer, Bert Ho, and Mark C. Manning, in Pharmaceutical Biotechnology, Volume 13, John F. Carpenter and Mark C. Manning, Eds., Kluwer Academic/Plenum Press, New York, 2002, 85-107.
"Chemical Instability in Peptide and Protein Pharmaceuticals", Elizabeth M. Topp, Lei Zhang, Hong Zhao, Robert W. Payne, Gabriel J. Evans, and Mark Cornell Manning, in: Formulation and Process Development Strategies for Manufacturing of a Biopharmaceutical (F. Jameel and S. Hershenson, Eds.), 2010, 41-67.
"Prediction of Aggregation Propensity from Primary Sequence Information", Mark Cornell Manning, Gabriel J. Evans, Cody M. Van Pelt, and Robert W. Payne, in: Formulation and Process Development Strategies for Manufacturing of a Biopharmaceutical (F. Jameel and S. Hershenson, Eds.), 2010, 329-347.
"Protein Stability during Bioprocessing", Mark Cornell Manning, Gabriel J. Evans, and Robert W. Payne, in: Formulation and Process Development Strategies for Manufacturing of a Biopharmaceutical (F. Jameel and S. Hershenson, Eds.), 2010, 605-624.